US Patent Issued to NURIX THERAPEUTICS on March 24 for "Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway" (California Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,722, issued on March 24, was assigned to NURIX THERAPEUTICS INC. (San Francisco).

"Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway" was invented by Daisuke Kato (San Francisco), Zef Konst (San Francisco), Jeffrey Mihalic (San Francisco), Daniel W. Robbins (San Francisco) and Arthur T. Sands (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, c...